Bart Frizzell to Humans
This is a "connection" page, showing publications Bart Frizzell has written about Humans.
Connection Strength
0.106
-
Datta M, Taylor ML, Frizzell B. Dietary and serum lycopene levels in prostate cancer patients undergoing intensity-modulated radiation therapy. J Med Food. 2013 Dec; 16(12):1131-7.
Score: 0.025
-
Able CM, Bright M, Frizzell B. Quality control of high-dose-rate brachytherapy: treatment delivery analysis using statistical process control. Int J Radiat Oncol Biol Phys. 2013 Mar 01; 85(3):828-33.
Score: 0.022
-
Frizzell B, Sinha D, Williams T, Reed CE, Sherman CA, Turrisi A. Influence of celiac axis lymph nodes in the definitive treatment of esophageal cancer. Am J Clin Oncol. 2003 Jun; 26(3):215-20.
Score: 0.012
-
Frizzell B, Stith M, Jenrette J. Management of treatment-resistant cutaneous sarcoidosis with radiation. Am J Clin Oncol. 2002 Dec; 25(6):573-5.
Score: 0.012
-
Hughes RT, Beuerlein WJ, O'Neill SS, Porosnicu M, Lycan TW, Waltonen JD, Frizzell BA, Greven KM. Human papillomavirus-associated squamous cell carcinoma of the larynx or hypopharynx: Clinical outcomes and implications for laryngeal preservation. Oral Oncol. 2019 11; 98:20-27.
Score: 0.009
-
LeCompte MC, Chung SA, McKee MM, Marshall TG, Frizzell B, Parker M, Blackstock AW, Farris MK. Simple and Rapid Creation of Customized 3-dimensional Printed Bolus Using iPhone X True Depth Camera. Pract Radiat Oncol. 2019 Jul - Aug; 9(4):e417-e421.
Score: 0.009
-
Datta M, Shaw EG, Lesser GJ, Case LD, Vitolins MZ, Schneider C, Frizzell B, Sullivan C, Lively M, Franzmann E, Hu JJ. A Randomized Double-Blind Placebo-Controlled Trial of Fruit and Vegetable Concentrates on Intermediate Biomarkers in Head and Neck Cancer. Integr Cancer Ther. 2018 03; 17(1):115-123.
Score: 0.008
-
Vitolins MZ, Griffin L, Tomlinson WV, Vuky J, Adams PT, Moose D, Frizzell B, Lesser GJ, Naughton M, Radford JE, Shaw EG. Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer. J Clin Oncol. 2013 Nov 10; 31(32):4092-8.
Score: 0.006
-
Butler JM, Case LD, Atkins J, Frizzell B, Sanders G, Griffin P, Lesser G, McMullen K, McQuellon R, Naughton M, Rapp S, Stieber V, Shaw EG. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Int J Radiat Oncol Biol Phys. 2007 Dec 01; 69(5):1496-501.
Score: 0.004